Fanny Mochel is an associate professor of genetics at the University Pierre and Marie Curie (UPMC). She received her MD in Genetics in 2005 at the University Paris Descartes, her PhD in Neuroscience in 2010 at UPMC and is board certified in inborn errors of metabolism. Dr Mochel runs a neurometabolic clinic at La Pitié-Salpêtrière university hospital and is the head of the Neurometabolic research group. She is co-chair of the French society for inborn of errors of metabolism in adults and a scientific board member of the Fondation Lejeune. Her research is focused on the characterization and treatment of brain energy deficiencies in neurodegenerative diseases, especially Huntington disease. Her major areas of expertise are the identification of neurometabolic biomarkers in vitro (metabolomics) and in vivo (nuclear magnetic resonance spectroscopy) as well as therapeutic approaches targeting the Krebs cycle (patents WO 2008068230 A1 and WO 2014093901 A1).